Table 1 Clinical characteristics of patients in the cohort
Parameter | Result |
|---|---|
Age in years (Interquartile range) | 45.2 (34.7–55.5) |
Males | 20 (51 %) |
Systemic hypertension | 14 (36 %) |
New York Heart Association Class I/II | 29 (74 %)/10 (26 %) |
Atrial fibrillation | 5 (13 %) |
Ventricular tachycardia | 5 (13 %) |
Device – Permanent pacemaker/Automated implantable cardioverter defibrillator | 1 (3 %)/3 (8 %) |
Enzyme replacement therapy | 27 (69 %) |
Renal disease | |
Proteinuria | 16 (41 %) |
Dialysis/Kidney Transplant | 3 (8 %)/3 (8 %) |
Other clinical manifestations | |
Stroke/Transient ischemic attack | 12 (31 %) |
Auditory manifestations | 25 (64 %) |
Acroparesthesia | 26 (67 %) |
Gastrointestinal tract involvement | 14 (36 %) |
Cutaneous manifestations | 18 (46 %) |